You are here

  • Home
  • Online First
  • The impact of rheumatoid factor and ACPA on bone erosion in rheumatoid arthritis

Article Text

Article menu

other Versions

Download PDFPDF
Correspondence response
The impact of rheumatoid factor and ACPA on bone erosion in rheumatoid arthritis
  1. Carolin Hecht,
  2. Georg Schett,
  3. Stephanie Finzel
  1. Department of Internal Medicine 3, University of Erlangen-Nuremberg, Erlangen, Germany
  1. Correspondence to Professor Georg Schett, Department of Rheumatology, University of Erlangen, Erlangen 91054, Germany; georg.schett{at}uk-erlangen.de

http://dx.doi.org/10.1136/annrheumdis-2014-206631

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    In their letter, Van Steenbergen and colleagues present data on the radiographic progression in rheumatoid arthritis (RA) patients stratified for anti-citrullinated protein antibody (ACPA) and rheumatoid factors (RFs) in two different patient cohorts.1 They show that the presence of ACPA is associated with a more pronounced progression of structural damage when scoring conventional radiographs by the standardised Sharp–van der Heijde method.1 These findings (i) underline previous radiographic findings that ACPAs are associated with radiographic progression in RA,2 (ii) stay in line with the known pathophysiologic function …

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles